Advanced RNA Sequencing Enrichment Tools Promise a More Comprehensive Transcriptome with Less Sequencing
By LabMedica International staff writers Posted on 12 Nov 2014 |
Image: The SeqCap lncRNA Enrichment Kit (Photo courtesy of Roche NimbleGen).
Biotech and other life sciences researchers working with RNA sequencing techniques will benefit from a recently introduced target enrichment system.
The Roche NimbleGen (Madison, WI, USA) SeqCap RNA Target Enrichment System for RNA-Seq applications includes a comprehensive lncRNA (long non-coding RNA) design and a full range of custom enrichment offerings including the SeqCap EZ Library.
The SeqCap RNA System was developed, in part, to provide a solution to the problem of increasing sensitivity to low-abundance transcripts without introducing any systematic bias. This was necessary, as a majority of the RNA-Seq reads are from a small number of highly expressed genes that mask genes present in low abundance.
The SeqCap EZ Library is a liquid-based enrichment technology, which enables the targeted capture for subsequent sequencing of the exome or a targeted subset of genes. SeqCap EZ Library is compatible with various sequencing chemistries and with the addition of the Caliper Life Sciences (Hopkinton, MA, USA) Sciclone NGS Workstation, provides a comprehensive high-throughput target enrichment solution.
“This is another step towards our goal of providing a complete solution to basic, translational and clinical researchers,” said Dr. Rebecca Selzer, president of Roche NimbleGen. “The SeqCap RNA products, together with the SeqCap EZ and Epi Systems, offer the genomics community comprehensive target enrichment tools for genomic DNA sequencing, bisulfite sequencing, and transcriptome research.”
Related Links:
Roche NimbleGen
Caliper Life Sciences
The Roche NimbleGen (Madison, WI, USA) SeqCap RNA Target Enrichment System for RNA-Seq applications includes a comprehensive lncRNA (long non-coding RNA) design and a full range of custom enrichment offerings including the SeqCap EZ Library.
The SeqCap RNA System was developed, in part, to provide a solution to the problem of increasing sensitivity to low-abundance transcripts without introducing any systematic bias. This was necessary, as a majority of the RNA-Seq reads are from a small number of highly expressed genes that mask genes present in low abundance.
The SeqCap EZ Library is a liquid-based enrichment technology, which enables the targeted capture for subsequent sequencing of the exome or a targeted subset of genes. SeqCap EZ Library is compatible with various sequencing chemistries and with the addition of the Caliper Life Sciences (Hopkinton, MA, USA) Sciclone NGS Workstation, provides a comprehensive high-throughput target enrichment solution.
“This is another step towards our goal of providing a complete solution to basic, translational and clinical researchers,” said Dr. Rebecca Selzer, president of Roche NimbleGen. “The SeqCap RNA products, together with the SeqCap EZ and Epi Systems, offer the genomics community comprehensive target enrichment tools for genomic DNA sequencing, bisulfite sequencing, and transcriptome research.”
Related Links:
Roche NimbleGen
Caliper Life Sciences
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples